Clinical trial Recruiting at 1 site Observational Ages 40 to 75

Lung macrophage patterns in COPD-susceptible smokers

Official title: Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers

Run by University of California, San Francisco · NCT04722835 · Data updated 2026-11-12

This study tests whether lung macrophage features differ in smokers who may be at risk for COPD, by comparing people with and without air trapping but with preserved lung function.

Quick facts

Study typeObservational
Ages40 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations3 sites (San Francisco, California and 2 other locations)
StatusRecruiting
StartedMarch 1, 2021
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedJune 4, 2026
Trial IDNCT04722835 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Smokers aged 40–75 with ≥20 pack-years, preserved spirometry, and classified by RV/TLC as either normal or abnormal.

Probably not a fit

Individuals with existing COPD or asthma or those unable to undergo bronchoscopy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational pilot study enrolling 20 adults aged 40–75 with a significant smoking history but no COPD or asthma and no airflow obstruction. Participants will be stratified by air trapping (RV/TLC) and undergo bronchoscopy with bronchoalveolar lavage to collect lung macrophages and BAL fluid, plus comprehensive clinical and quality-of-life assessments. Molecular, functional, and transcriptomic analyses of alveolar macrophages, along with protease activity measurements, will be correlated with an air-trapping phenotype to identify potential biological signatures of susceptibility to COPD. Findings will inform the design of a larger future study exploring mechanisms of COPD development in smokers.

Why it matters

Potential benefit: Identifying biological markers of COPD susceptibility could guide prevention strategies for high-risk smokers.

How similar studies have gone: Prior observational work has begun to characterize lung macrophages in smokers, but this exact approach with BAL-based phenotyping is exploratory and mechanistic for COPD susceptibility.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages between 40 to 75 years old.
* History of at least 20 pack-years of smoking.
* No diagnosis of COPD or asthma.
* No spirometric evidence of airflow obstruction as determined by FEV1/FVC ratio ≥0.7.
* FEV1 and FVC \>lower limit of normal.
* Less than 1 pack-year history of tobacco smoking and no tobacco use within the past 12 months.
* Subjects will be divided into two groups by their RV/TLC:

Normal RV/TLC Group:

• Plethysmographic RV/TLC equal or less than lower limit of normal.

Abnormal RV/TLC Group:

• Plethysmographic RV/TLC higher than lower limit of normal.

Exclusion Criteria:

* Any history of IV drug use or inhalation of recreational drugs other than marijuana: A- within the past 20 years. B- more than 100 times IV drug usage. C- longer than 1 year usage.
* Marijuana use \>400 joints in lifetime or any within past 6 months.
* Inability to walk briskly, run on treadmill, or pedal on ergometer to perform the study-required exercise level.
* Pregnant/breast feeding.
* Serious and active heart conditions- defined by stable or unstable angina, recent myocardial infarction (within the last 2 years), active congestive heart failure, ischemic cardiomyopathy.
* Liver cirrhosis.
* History of chronic active Hepatitis B or C.

Where it's running

  • San Francisco VA Medical Center
    San Francisco, California, United States
    Recruiting
  • Zuckerberg San Francisco General Hospital and Trauma Center
    San Francisco, California, United States
    Active not recruiting
  • University of California, San Francisco
    San Francisco, California, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.